Management of Unilateral Tonsillar Hypertrophy
Tonsillectomy is the recommended treatment for unilateral tonsillar hypertrophy, particularly when associated with concerning clinical features or obstructive symptoms. 1
Diagnostic Evaluation
- Assess tonsillar size using the Brodsky scale (grades 0-4) to objectively document the degree of asymmetry 1, 2
- Evaluate for concerning features that increase risk of malignancy:
Treatment Algorithm
Indications for Tonsillectomy
- Unilateral tonsillar hypertrophy with ANY of the following:
Surgical Approach
- Complete tonsillectomy is preferred over partial tonsillectomy (tonsillotomy) for unilateral tonsillar hypertrophy 1
- Consider adenoidectomy concurrently if sleep-disordered breathing is present, as combined adenotonsillectomy provides better outcomes than tonsillectomy alone 1, 6
- Intraoperative administration of a single dose of intravenous dexamethasone (0.5 mg/kg, maximum 8-25 mg) is recommended to reduce postoperative pain, nausea, and vomiting 7
Alternative Management
- For asymptomatic unilateral tonsillar hypertrophy without concerning features:
- For poor surgical candidates who require intervention:
- Radiofrequency tonsil reduction may be considered, though it is less effective than traditional tonsillectomy 1
Special Considerations
Risk of Malignancy
- The risk of malignancy in unilateral tonsillar enlargement varies:
- Most common malignancies include lymphoma and rarely chronic lymphocytic leukemia/small lymphocytic lymphoma 5, 8
- Non-malignant causes include actinomycosis and other infections 9
Postoperative Considerations
- Potential complications include pain, bleeding, infection, and respiratory difficulties 1, 6
- Complete resolution of obstructive symptoms occurs in 60-70% of normal-weight children but only 10-25% of obese children 7, 2
- Consider postoperative polysomnography in patients with persistent symptoms or risk factors for persistent sleep-disordered breathing 1, 2